Projects
This section presents pharmaceutical projects that are announced from time-to-time around the world.
Luina Bio Expands with New Manufacturing Facilities
Luina Bio plans to expand its new Biomanufacturing GMP and development facility
Eurofins Invests US$169 million to Expand the Chemistry Site in Spain
Eurofins with an investment of US$169 million plans for expansion of the chemistry site for the synthesis of chemicals and purification of drugs The new manufacturing facility will be located in Murcia, Spain
Samsung Biologics Plans to Construct New Manufacturing Facility
Samsung Biologics plans to expand its presence with the construction of a new manufacturing facility located at Incheon
Marker Therapeutics Plans to Construct New Manufacturing Facility in Texas
Marker Therapeutics plans to construct a new manufacturing facility to support clinical development of MultiTAASpecific T cell therapy product candidates The new location will be constructed at Houston, TX, nearby George Bush Intercontinental Airport
Bionova Constructs New GMP Biologics Manufacturing Center
Bionova plans to construct a new stateoftheart biologics manufacturing facility The new GMP biologics manufacturing center is constructed with an area covering 36,000 sq ft This new biomanufacturing site will make use of singleuse technologies
Tonix Pharmaceuticals Plans to Build New R & D Centre
Tonix Pharmaceuticals Holding Corp builds a new RD centre for developing vaccines and proteinbased therapeutics The new facility will be located in Massachusetts
Merck to Invest US$118 million in New Gene Therapy Manufacturing Plant
Merck, with an investment of US$118 million 100 million plans to build a new gene therapy manufacturing capacity to double the size of the existing capacity The new manufacturing site will be located in Carlsbad, California, USA
Advanced Accelerator Applications Plans to Build Second US Manufacturing Site in Indianapolis
Advanced Accelerator Applications plans to build a new manufacturing facility for currently approved therapy and pipeline drug candidates in Indianapolis The expansion would be the second US manufacturing site for targeted radioLigand therapy
WACKER Announces Plans to Invest in Amsterdam Biotech Site
WACKER has recently announced investment plans for its production facilities of biologics, LMPs live microbial products and vaccines located at Amsterdam site, at a middoubledigit millioneuro amount
Marken Expands GMP Facility in Frankfurt
Marken has announced its plans to double the space of GMP facility by expanding in Frankfurt to meet the frozen room storage capabilities in anticipation of the COVID19 vaccine and storage needs
